DRAK2 Polyclonal Antibody

Alias:STK17B;DRAK2;Serine/threonine-protein kinase 17B;DAP kinase-related apoptosis-inducing protein kinase 2

CatalogNo:HJRLT1411

Specifications

50μL;100μL

Delivery date

Spot

Target

DRAK2

Reactivity

Human,Mouse,Rat

Application - After Update

WB,IHC,IF,ELISA

MW(Observed)

45kD

Host Species

Rabbit

Isotype

IgG

Modify

Unmodified

Recommended dilution ratio

WB 1:500-1:2000;IHC 1:100-1:300;ELISA 1:40000;IF 1:50-200

compose

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Store

-15°C to -25°C/1 year(Do not lower than -25°C)

Soncentration

1 mg/ml

Clonality

Polyclonal

Immunogen

The antiserum was produced against synthesized peptide derived from human STK17B. AA range:251-300

Specificity

DRAK2 Polyclonal Antibody detects endogenous levels of DRAK2 protein.

Gene name

STK17B

Protein name

Serine/threonine-protein kinase 17B

Organism-1

Human